<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0035">
 <label>7</label>
 <element-citation publication-type="journal" id="rf0035">
  <person-group person-group-type="author">
   <name>
    <surname>Infantino</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Damiani</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gobbi</surname>
    <given-names>F.L.</given-names>
   </name>
   <name>
    <surname>Grossi</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Lari</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Macchia</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives</article-title>
  <source>Isr. Med. Assoc. J.</source>
  <volume>22</volume>
  <issue>4</issue>
  <year>2020</year>
  <fpage>203</fpage>
  <lpage>210</lpage>
  <pub-id pub-id-type="pmid">32286019</pub-id>
 </element-citation>
</ref>
